Arvinas (ARVN) Total Current Liabilities (2017 - 2026)

Arvinas' (ARVN) quarterly Total Current Liabilities came in at $115.9 million in Q1 2026, down 45.84% year-on-year from $214.0 million in Q1 2025, and down 18.67% quarter-over-quarter from $142.5 million in Q4 2025.

Arvinas (ARVN) Total Current Liabilities (2017 - 2026) Analysis & Trends

Arvinas' Total Current Liabilities history runs 10 years deep, the most recent figure standing at $115.9 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities fell 45.84% year-over-year to $115.9 million in Q1 2026; TTM through Mar 2026 was $115.9 million, a 45.84% decrease from a year earlier, with the FY2025 full-year figure at $142.5 million, down 37.99% from the prior year.
  • Total Current Liabilities fell to $115.9 million in Q1 2026 per ARVN's latest filing, from $142.5 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $347.2 million in Q2 2024 and bottomed at $115.9 million in Q1 2026.
  • The 5-year median for Total Current Liabilities is $240.8 million (2024), against an average of $238.2 million.
  • Across the five-year window, Total Current Liabilities soared 489.52% in 2022 and tumbled 54.55% in 2025, its largest moves.
  • Year by year, Total Current Liabilities stood at $295.1 million in 2022, then fell by 12.88% to $257.1 million in 2023, then fell by 10.62% to $229.8 million in 2024, then slumped by 37.99% to $142.5 million in 2025, then fell by 18.67% to $115.9 million in 2026.
  • Per Business Quant, the three latest ARVN Total Current Liabilities figures stand at $115.9 million (Q1 2026), $142.5 million (Q4 2025), and $144.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 56.01 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 66.94 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 13.42 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.81 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 289.60 Mn
10 Arvinas 512.64 Mn -102.26 Mn - 115.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 115.90 Mn
Dec 31, 2025 142.50 Mn
Sep 30, 2025 144.90 Mn
Jun 30, 2025 157.80 Mn
Mar 31, 2025 214.00 Mn
Dec 31, 2024 229.80 Mn
Sep 30, 2024 275.90 Mn
Jun 30, 2024 347.20 Mn
Mar 31, 2024 240.80 Mn
Dec 31, 2023 257.10 Mn
Sep 30, 2023 317.30 Mn
Jun 30, 2023 306.90 Mn
Mar 31, 2023 282.90 Mn
Dec 31, 2022 295.10 Mn
Sep 30, 2022 244.60 Mn
Jun 30, 2022 238.20 Mn
Mar 31, 2022 238.00 Mn
Dec 31, 2021 261.70 Mn
Sep 30, 2021 182.51 Mn
Jun 30, 2021 41.82 Mn